The promise of translational and personalised approaches for paediatric obstructive sleep apnoea: an 'Omics'

Hui-Leng Tan1, Leila Kheirandish-Gozal, David Gozal

  • 1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, , London, UK.

Thorax
|February 20, 2014
PubMed

Insights

Obstructive sleep apnoea (OSA) causes widespread harm through inflammation and oxidative stress. Advanced

Area of Science:

  • Sleep Medicine
  • Genetics
  • Molecular Biology

Background:

  • Obstructive sleep apnoea (OSA) is linked to cardiovascular, metabolic, and neurocognitive issues.
  • Pathophysiological mechanisms of OSA and its varied clinical presentations remain unclear.
  • Inflammatory cascades and oxidative stress are suspected mediators of OSA-related damage.

Purpose of the Study:

  • To review recent advances in understanding genotype-phenotype interactions in OSA.
  • To explore the role of epigenetics, genomics, and proteomics in OSA.
  • To highlight how 'Omics' approaches can advance personalized diagnosis and management of OSA.

Main Methods:

  • Review of current literature on OSA genetics and molecular mechanisms.
  • Synthesis of findings on genotype-phenotype correlations.
  • Discussion of 'Omics' technologies (genomics, proteomics, epigenetics) in sleep medicine.

Main Results:

  • Emerging evidence links specific genetic profiles to OSA phenotypes and end-organ damage.
  • Epigenetic modifications may influence OSA susceptibility and severity.
  • 'Omics' data provide a deeper understanding of OSA's molecular underpinnings.

Conclusions:

  • 'Omics' technologies offer transformative potential for OSA research and clinical practice.
  • Understanding genetic and molecular factors is crucial for personalized OSA management.
  • Further research into genotype-phenotype interactions will elucidate OSA's complex pathophysiology.

Keywords:
Sleep apnoea

Related Concept Videos

Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.5K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
3.4K
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

2.1K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253